Search results
Results From The WOW.Com Content Network
As an antihistamine, doxylamine is an inverse agonist of the histamine H 1 receptor. As a first-generation antihistamine, it typically crosses the blood–brain barrier into the brain, thereby producing a suite of sedative and hypnotic effects that are mediated by the central nervous system. (N.b.:
Bedsure Orthopedic Dog Bed $59.99 from Amazon Available in a wide range of sizes and colors, this super comfy bed is made from high-density egg crate foam and features a four-sided bolster design ...
This list of dog breeds includes both extant and extinct dog breeds, varieties and types. A research article on dog genomics published in Science/AAAS defines modern dog breeds as "a recent invention defined by conformation to a physical ideal and purity of lineage".
Excedrin is a combination medication composed of acetaminophen, aspirin, and caffeine. These medications treat migraine headache in a variety of ways. Acetaminophen is a fever reducer and painkiller. Its precise mechanism is unknown. It is known that it mostly affects the brain and spinal cord, which are parts of the central nervous system.
Drug manufacturer companies, which account for about 35% of the healthcare sector, have seen shares rise 13% year to date. And Eli Lilly has been at the head of the pharmaceutical charge due to ...
Lisa Strauss, a psychologist specializing in cognitive behavioral treatment of sleep disorders, has suggested designating different sides or ends of the bed for reading and sleeping. Freshen the ...
Kaopectate is an orally taken medication from invented by Jonathan Jordan for the treatment of mild diarrhea. It is also sometimes used to treat indigestion, nausea, and stomach ulcers. The active ingredients have varied over time, and are different between the United States and Canada. The original active ingredients were kaolinite and pectin.
The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the "non-drowsy" claim from its ...